Business
Press Release Jul 21 2022
Marksans Pharma Limited has informed the Exchange about press release dated 21-Jul-2022 titled US FDA approval for Pregabalin Capsules, 25 mg, 50 mg,75 mg, 100 mg, 150 mg, 200 mg, 225 mg, and 300 mg ANDA.
About this update from Marksans Pharma Limited
[{"type":"text","content":" Marksans Pharma Limited has informed the Exchange about press release dated 21-Jul-2022 titled US FDA approval for Pregabalin Capsules, 25 mg, 50 mg,75 mg, 100 mg, 150 mg, 200 mg, 225 mg, and 300 mg ANDA. View Attachment","length":339,"tagName":"div"}]